MASS 908 Devices Inc
- Stocks
- Healthcare
- NASDAQ: MASS
Price (delayed)
$6.42
Market cap
$230.23M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.54
Enterprise value
$154.83M
908 Devices, a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the U.S. Border Patrol selected the MX908® – a handheld, battery-powered,
Highlights
908 Devices's net income has soared by 76% from the previous quarter and by 49% YoY
The EPS has surged by 75% since the previous quarter and by 50% year-on-year
The quick ratio has surged by 117% since the previous quarter but it has declined by 8% year-on-year
The gross margin has declined by 3.9% year-on-year
Key stats
What are the main financial stats of MASS
Market
Valuations
Earnings
Shares outstanding
35.86M
Market cap
$230.23M
Enterprise value
$154.83M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.42
Price to sales (P/S)
3.7
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.52
Revenue
$61.42M
Gross profit
$30.39M
Operating income
-$85.77M
Net income
-$17.69M
EBIT
-$17.9M
EBITDA
-$13.25M
Free cash flow
-$35.77M
Per share
Balance sheet
Liquidity
EPS
-$0.54
EPS diluted
-$0.54
Free cash flow per share
-$1.01
Book value per share
$4.51
Revenue per share
$1.74
TBVPS
$4.47
Total assets
$196.03M
Total liabilities
$36.6M
Debt
$3.77M
Equity
$159.42M
Working capital
$129.44M
Debt to equity
0.02
Current ratio
7.62
Quick ratio
6.71
Net debt/EBITDA
5.69
Margins
Efficiency
Dividend
EBITDA margin
-21.6%
Gross margin
49.5%
Net margin
-28.8%
Operating margin
-139.7%
Return on assets
-9.5%
Return on equity
-12.6%
Return on invested capital
-30.4%
Return on capital employed
-10.1%
Return on sales
-29.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MASS stock price
How has the 908 Devices stock price performed over time
Intraday
-1.98%
1 week
-13.48%
1 month
-0.93%
1 year
26.38%
YTD
191.82%
QTD
-9.96%
Financial performance
How have 908 Devices's revenue and profit performed over time
Revenue
$61.42M
Gross profit
$30.39M
Operating income
-$85.77M
Net income
-$17.69M
Gross margin
49.5%
Net margin
-28.8%
908 Devices's operating income has shrunk by 129% YoY but it has increased by 4.6% QoQ
MASS's operating margin has dropped by 80% year-on-year but it is up by 7% since the previous quarter
908 Devices's net income has soared by 76% from the previous quarter and by 49% YoY
The company's net margin has surged by 76% QoQ and by 60% YoY
Price vs fundamentals
How does MASS's price correlate with its fundamentals
Growth
What is 908 Devices's growth rate over time
Valuation
What is 908 Devices stock price valuation
P/E
N/A
P/B
1.42
P/S
3.7
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.52
The EPS has surged by 75% since the previous quarter and by 50% year-on-year
The P/B is 58% below the 5-year quarterly average of 3.4 but 58% above the last 4 quarters average of 0.9
908 Devices's equity has increased by 39% QoQ
MASS's price to sales (P/S) is 70% lower than its 5-year quarterly average of 12.4 but 54% higher than its last 4 quarters average of 2.4
MASS's revenue is up by 28% year-on-year and by 3% since the previous quarter
Efficiency
How efficient is 908 Devices business performance
The company's return on equity has surged by 76% QoQ and by 40% YoY
The ROIC has soared by 76% since the previous quarter and by 55% year-on-year
The return on sales has surged by 76% since the previous quarter and by 59% year-on-year
MASS's ROA has soared by 76% from the previous quarter and by 44% YoY
Dividends
What is MASS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MASS.
Financial health
How did 908 Devices financials performed over time
The quick ratio has surged by 117% since the previous quarter but it has declined by 8% year-on-year
The current ratio has surged by 86% since the previous quarter but it has declined by 9% year-on-year
The company's debt is 98% lower than its equity
MASS's debt to equity has dropped by 50% since the previous quarter and by 33% year-on-year
908 Devices's equity has increased by 39% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.